Table 1.
Genes with a fitness defect in naïve macrophages | |||||||
---|---|---|---|---|---|---|---|
Gene ID | Product description | Naïve BMDM vs. HFF Control fitness (mean ± SEM) | p value (one-sided Wilcoxon signed-rank test) | Cohen’s d | IFNγ vs. Naïve BMDM fitness | In vitro phenotype in HFFs53 | In vivo fitness55,84 |
TGGT1_249580 | TgApiAT6-3 | −4.2 ± 1.1 | 0.001 | 7.6 | −0.2 | 0.5 | N/A |
TGGT1_247360 | PAP2 superfamily protein | −3.2 ± 1.0 | 0.002 | 5.8 | −1.2 | 1.6 | N/A |
TGGT1_250880 | Kinase, pfkB family protein (Adenosine Kinase) | −1.8 ± 0.4 | 0.002 | 3.4 | 1.2 | 1.4 | N/A |
TGGT1_290860 | TgApiAT6-2 | −1.5 ± 1.2 | 0.03 | 2.8 | 0.5 | 1.0 | N/A |
TGGT1_248560 | Hypothetical protein; homology to 26 S Proteasome regulatory subunit RPN2 (Swiss-Model) | −1.5 ± 0.5 | 0.003 | 2.8 | 0.1 | 0.3 | N/A |
TGGT1_308075 | Hypothetical protein; homology to DNAse Pyocin AP41 (Swiss-Model) | −1.3 ± 0.2 | 0.003 | 2.5 | 0.7 | 1.5 | N/A |
TGGT1_224840 | 3'5’-cyclic nucleotide phosphodiesterase domain-containing protein | −1.3 ± 0.3 | 0.004 | 2.4 | 0.3 | 0.4 | N/A |
TGGT1_262650 | WD domain, G-beta repeat-containing protein | −1.1 ± 0.4 | 0.007 | 2.1 | 0.2 | 0.4 | N/A |
TGGT1_269390 | CRAL/TRIO domain-containing protein | −1.0 ± 0.6 | 0.03 | 2.0 | −0.1 | 0.1 | N/A |
Genes with a fitness defect in IFNγ-activated macrophages | |||||||
---|---|---|---|---|---|---|---|
Gene ID | Product description | IFNγ vs. naïve BMDM fitness (mean ± SEM) | p value (one-sided Wilcoxon signed-rank test) | Cohen’s d | Naïve BMDM vs. HFF control Fitness | In vitro phenotype in HFFs53 | In vivo fitness55,84 |
TGGT1_269620 | DNA repair protein-like (Swiss-model) | −4.0 ± 1.6 | 0.004 | 2.9 | 1.5 | −0.3 | N/A |
TGGT1_209500 | DNA repair protein-like (HHpred) | −3.6 ± 1.8 | 0.006 | 2.7 | 0.4 | 0.1 | N/A |
TGGT1_295340 | UV excision repair protein Rad23 protein | −3.5 ± 1.0 | 0.003 | 2.6 | 1.4 | −0.4 | N/A |
TGGT1_316250 | GRA45 | −3.3 ± 0.4 | 0.002 | 2.4 | 1.0 | 1.2 | N/A |
TGGT1_232670 | Cytohesin-3-like; GEF of Arf6 (Swiss-Model) | −3.3 ± 0.8 | 0.003 | 2.4 | 0.3 | 1.5 | N/A |
TGGT1_321530 | Cathepsin L (CPL) | −3.3 ± 0.9 | 0.003 | 2.4 | 1.7 | 0.7 | N/A |
TGGT1_263560 | Putative GRA (Supplementary Fig. 5i) | −3.0 ± 1.2 | 0.006 | 2.2 | 1.5 | 0.5 | N/A |
TGGT1_208370 | GRA46 | −3.0 ± 1.6 | 0.008 | 2.1 | 1.5 | 1.8 | N/A |
TGGT1_228300 | CCDC25 protein | −2.9 ± 0.6 | 0.003 | 2.1 | 0.3 | −1.1 | N/A |
TGGT1_215220 | GRA22 | −2.9 ± 1.8 | 0.02 | 2.1 | 1.1 | 1.0 | Peritoneum |
TGGT1_314500 | SUB2 | −2.8 ± 1.4 | 0.01 | 2.0 | 0.8 | 0.3 | N/A |
TGGT1_227560 | Putative IWS1 transcription factor | −2.7 ± 1.7 | 0.02 | 1.8 | 1.3 | −0.7 | N/A |
TGGT1_200290 | ROM1 | −2.4 ± 1.3 | 0.01 | 1.7 | 0.2 | 0.8 | N/A |
TGGT1_240980 | Cytoplasmic dynein-like (Swiss-Model/HHpred) | −2.4 ± 0.9 | 0.007 | 1.7 | 0.3 | −1.0 | N/A |
TGGT1_276940 | Putative ribosome associated membrane protein RAMP4 | −2.4 ± 1.4 | 0.02 | 1.7 | −0.4 | 0.4 | N/A |
TGGT1_222050 | Putative methylcitrate synthase (Swiss-Model) | −2.2 ± 1.3 | 0.03 | 1.5 | 0.6 | 0.7 | N/A |
TGGT1_269950a | Putative GRA (ToxoDB.org); homology to QSOX (HHpred) | −2.1 ± 1.2 | 0.2 | 1.4 | 1.4 | 0.4 | Peritoneum |
Upper panel: nine top hits, selected from 193 naïve BMDM fitness-conferring genes, with at least four sgRNAs present in the last passage of HFF control and ≥2-fold lower fitness (fitness score ≤ −1) in naïve BMDMs vs. HFF control. Genes with a mean Naïve BMDM fitness > −1.5 and a mean HFF control fitness < −1.5 were removed.
Lower panel: 16 top hits (not including TGGT1_269950), selected from 232 IFNγ fitness-conferring genes, with at least four sgRNAs present in the 3rd passage of naïve BMDMs and a ≥4-fold lower fitness (fitness score ≤ −2) in IFNγ vs. naïve BMDMs. Genes with a mean IFNγ fitness > −0.5 and a mean naïve BMDM fitness < 0 were removed. The genes are ranked according to the mean fitness (naïve BMDM vs. HFF control, upper panel; IFNγ vs. naïve BMDM, lower panel). See Supplementary Data 1 for the complete list.
aTGGT1_269950 was confirmed as an IFNγ fitness-conferring gene (Fig. 2f), although it does not fit the above criteria.